☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR For the transition period from to Commission file number 001-4802 Becton, Dickinson and Company (Exact name of registrant as specified in its charter) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 (201) 847-6800 (Address of principal executive offices) (Zip Code) (Registrant's telephone number, including area code) | --- | --- | --- | |------------------------ ...

AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous LesionsFRANKLIN LAKES, N.J. and OREM, Utah, Jan. 30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Techcyte, a world leader in artificial intelligence (AI)-based digital diagnostics, today announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and patholog ...

Becton Dickinson and Company (BDX) , popularly known as BD, is scheduled to report first-quarter fiscal 2024 results on Feb 1, before market open.In the last reported quarter, the company’s earnings per share (EPS) of $3.42 matched the Zacks Consensus Estimate. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on three occasions and matched once, delivering an earnings surprise of 4.5%, on average.Let’s check out the factors that have shaped BDX’s performance prior to t ...

Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced its collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications coupled with robotics-compatible reagent kits.This collaboration is likely to enable greater standardization and reduce human error when conducting large-scale single-cell multiomics experiments.Price PerformanceFor the past six months, BDX’s shares have lost 17.2% compared with the indu ...

The market expects Becton Dickinson (BDX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be rel ...

Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer RatesNAIROBI, Kenya, Jan. 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with the Kenyan Government through the National Cancer Institute-Kenya to advance access to critical cancer diagnostics for women in Kenya. Through this program, BD continues to drive its commitment toward ...

Companies to automate a critical step of high-throughput single-cell multiomics experimentsFRANKLIN LAKES, N.J., Jan. 23, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting lar ...

JHVEPhoto Becton, Dickinson and Company (NYSE:BDX) has underperformed the broader market and healthcare sector more broadly over the past few years. The stock has delivered a total return of 4% over the past 5 years. Comparably, during the same time period the S&P 500 has delivered a total return of 94% and the Health Care Select Sector SPDR ETF (XLV) has delivered a total return of 69%. Currently, the stock is rated a Hold by other Seeking Alpha analysts. There are four reasons why I disagree with this cha ...

Survey Conducted in the US, UK and Sweden Exposes Lack of Education on Options and Unclear Guidance on HPV TestingFRANKLIN LAKES, N.J., Jan. 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a Harris Poll survey of women in the U.S., U.K. and Sweden, which shines a spotlight on the differences in access to cervical cancer screening and prevention. The results of a Harris Poll survey conducted in the U.S., ...

FRANKLIN LAKES, N.J., Jan. 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 23, 2024, at 1:00 p.m. (ET). The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website. About BDBD is one of the largest global medical technology compa ...